This article is more than 5 years old. Information may no longer be current.

Second Sight posts second quarter net loss

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Second Sight Medical Products reported a net loss of $8 million, or $0.12 per share, in 2018’s second quarter compared with a net loss of $6.8 million, or $0.12 per share, in the same time period during 2017, according to a press release.

Net sales totaled $1.9 million in the quarter compared with $2.2 million a year ago.

General and administrative expenses decreased from $2.9 million in 2017’s second quarter to $2.6 million in 2018, which the company attributed to lower stock-based compensation charges.

Selling and marketing expenses and clinical and regulatory expenses both increased slightly from $2.4 million to $2.9 million and from $0.7 million to $1.1 million, respectively. Research and development costs went up to $2.4 million from $1.9 million.